150 related articles for article (PubMed ID: 28594322)
1. Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma.
Fianco G; Mongiardi MP; Levi A; De Luca T; Desideri M; Trisciuoglio D; Del Bufalo D; Cinà I; Di Benedetto A; Mottolese M; Gentile A; Centonze D; Ferrè F; Barilà D
Elife; 2017 Jun; 6():. PubMed ID: 28594322
[TBL] [Abstract][Full Text] [Related]
2. Caspase-8: A Novel Target to Overcome Resistance to Chemotherapy in Glioblastoma.
Fianco G; Contadini C; Ferri A; Cirotti C; Stagni V; Barilà D
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501030
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.
Kuwayama K; Matsuzaki K; Mizobuchi Y; Mure H; Kitazato KT; Kageji T; Nakao M; Nagahiro S
Neuro Oncol; 2009 Apr; 11(2):132-41. PubMed ID: 18812519
[TBL] [Abstract][Full Text] [Related]
4. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
Gupta P; Dixit D; Sen E
Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.
Zakaria Z; Tivnan A; Flanagan L; Murray DW; Salvucci M; Stringer BW; Day BW; Boyd AW; Kögel D; Rehm M; O'Brien DF; Byrne AT; Prehn JH
Br J Cancer; 2016 Jan; 114(2):188-98. PubMed ID: 26657652
[TBL] [Abstract][Full Text] [Related]
6. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
8. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma.
Xie TX; Xia Z; Zhang N; Gong W; Huang S
Oncol Rep; 2010 Mar; 23(3):725-32. PubMed ID: 20127012
[TBL] [Abstract][Full Text] [Related]
9. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
11. Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression Without Increasing Invasiveness.
Yan H; Romero-Lopez M; Frieboes HB; Hughes CC; Lowengrub JS
IEEE Trans Biomed Eng; 2017 Mar; 64(3):538-548. PubMed ID: 27723576
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory landscape of human brain tumors reveals an NFκB dependent cytokine pathway associated with mesenchymal glioblastoma.
Zanotto-Filho A; Gonçalves RM; Klafke K; de Souza PO; Dillenburg FC; Carro L; Gelain DP; Moreira JC
Cancer Lett; 2017 Apr; 390():176-187. PubMed ID: 28007636
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin expression and regulation in human glioblastoma, cultured human glioblastoma cell lines and pilocytic astrocytoma.
Metellus P; Voutsinos-Porche B; Nanni-Metellus I; Colin C; Fina F; Berenguer C; Dussault N; Boudouresque F; Loundou A; Intagliata D; Chinot O; Martin PM; Figarella-Branger D; Ouafik L
Eur J Cancer; 2011 Jul; 47(11):1727-35. PubMed ID: 21458987
[TBL] [Abstract][Full Text] [Related]
14. JSI-124 suppresses invasion and angiogenesis of glioblastoma cells in vitro.
Yuan G; Yan S; Xue H; Zhang P; Sun J; Li G
PLoS One; 2015; 10(3):e0118894. PubMed ID: 25789853
[TBL] [Abstract][Full Text] [Related]
15. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
16. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Lucio-Eterovic AK; Piao Y; de Groot JF
Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
[TBL] [Abstract][Full Text] [Related]
17. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.
Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G
J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization.
Dieterich LC; Mellberg S; Langenkamp E; Zhang L; Zieba A; Salomäki H; Teichert M; Huang H; Edqvist PH; Kraus T; Augustin HG; Olofsson T; Larsson E; Söderberg O; Molema G; Pontén F; Georgii-Hemming P; Alafuzoff I; Dimberg A
J Pathol; 2012 Nov; 228(3):378-90. PubMed ID: 22786655
[TBL] [Abstract][Full Text] [Related]
19. From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis.
Giusti I; Delle Monache S; Di Francesco M; Sanità P; D'Ascenzo S; Gravina GL; Festuccia C; Dolo V
Tumour Biol; 2016 Sep; 37(9):12743-12753. PubMed ID: 27448307
[TBL] [Abstract][Full Text] [Related]
20. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
